[Release of polymorphic forms of progesterone from dimethylpolysiloxane matrices].

M. Bernabei,G. Gamberini,V. Ferioli,R. Cameroni

Abstract:

What problem does this paper attempt to address?

The pH‐Dependent Local Anesthetic Activity of Diethylaminoethanol, a Procaine Metabolite

J. Butterworth,P. Lief,G. Strichartz

DOI: https://doi.org/10.1097/00000542-198804000-00005

IF: 8.986

1988-04-01

Anesthesiology

Abstract:To test whether the products of procaine hydrolysis have local anesthetic actions resembling those of procaine, the authors compared the ability of procaine and its metabolites diethylaminoethanol (DEAE) and para-aminobenzoic acid (PABA) to block compound action potentials in excised, desheathed frog and rat sciatic nerves. Studies were performed in solutions of impermeant buffers at pH 7.4 (corresponding to mammalian physiologic pH) and at pH 9.2 (close to the pKa of procaine and DEAE) to test for extracellular pH-dependent increases in drug permeation and potency. Both procaine and DEAE inhibited compound action potentials at pH 7.4 and 9.2 in a reversible and dose-dependent manner, and both were approximately ten-fold more potent at pH 9.2 that at pH 7.4, procine inhibiting the action potential height by 50% at 0.15 mM (pH 9.2) and 1.1 mM (pH 7.4), DEAE at 4 mM (pH 9.2) and 70 mM (pH 7.4). In contrast, PABA at concentrations up to 25 mM and at either pH failed to inhibit compound action potentials, and did not modigy the effects of DEAE when both drugs were given together. Procaine produced greater use-dependent block at the higher pH and at higher stimulation rates (100 Hz vs. 40 Hz); DEAE produced a lmost no use-dependent block. These observations suggest: I) that DEAE might account for some of the neuropharmacologic activity of procaine in techniques that favor the accumulation of metabolites (such as those requiring large doses or prolonged in fusios); and 2) that alkalinizatio of procaine and DEAE solutions appears to increase their potency for both resting and use-dependent block of action potentials.
Optimal Management of Incontinence-Associated Dermatitis in the Elderly

Mikel Gray

DOI: https://doi.org/10.2165/11311010-000000000-00000

2010-06-01

American Journal of Clinical Dermatology

Abstract:Incontinence-associated dermatitis (IAD), sometimes referred to as perineal dermatitis, is an inflammation of the skin associated with exposure to urine or stool. Elderly adults, and especially those in long-term care facilities, are at risk for urinary or fecal incontinence and IAD. Traditionally, IAD has received little attention as a distinct disorder, and it is sometimes confused with stage I or II pressure ulcers. However, a modest but growing body of research is beginning to provide insights into the epidemiology, etiology, and pathophysiology of IAD. In addition, recent changes in reimbursement policies from the US Center for Medicare and Medicaid Services regarding pressure ulcer prevention has focused attention on the differential diagnosis of IAD versus pressure ulcer, and its influence on pressure ulcer risk. Color, location, depth, and the presence or absence of necrotic tissue are visual indicators used to differentiate IAD from pressure-related skin damage. Prevention is based on avoiding or minimizing exposure to stool or urine combined with a structured skin-care program based on principles of gentle cleansing, moisturization, preferably with an emollient, and application of a skin protectant. Treatment of IAD focuses on three main goals: (i) removal of irritants from the affected skin; (ii) eradication of cutaneous infections such as candidiasis; and (iii) containment or diversion of incontinent urine or stool.

dermatology
Effectiveness of skin cleanser and protectant regimen on incontinence‐associated dermatitis outcomes in acute care patients: A cluster randomised trial

George Frederick Glass,Cheng Cheng Karine Goh,Run Qi Cheong,Zhi Lei Ong,Peck Chui Betty Khong,Ee‐Yuee Chan

DOI: https://doi.org/10.1111/iwj.13588

2021-05-07

International Wound Journal

Abstract:Skin cleansers and protectants protect skin from incontinent matter to reduce the risk of incontinence‐associated dermatitis (IAD), but their effectiveness treating established IAD in the tropics is unknown. We conducted an open‐label cluster randomised trial to compare the effectiveness of a combined regimen of (1) specialised skin cleansers with disposable body wipes and (2) either an acrylic terpolymer (T1) or zinc oxide (T2) skin protectant against disposable body wipes and zinc oxide protectant (control) in promoting IAD healing and reducing the risk of deterioration. Eighty‐four patients were recruited in a tertiary hospital in Singapore between April 2019 and January 2020 (T1: n = 23; T2: n = 37; Control: n = 24). Although not statistically significant, patients treated with T1 and T2 were 1.5 times as likely to experience IAD healing within seven days compared with the control (P = .66). Healing was more pronounced in participants with skin loss treated with T1 or T2. No treatment was superior in preventing IAD deterioration, the prevalence of which remained small (8%‐14%). While skin cleaning and protectants reduced the overall risk of skin deterioration, the addition of skin cleansers enhanced IAD healing within a short period, an important consideration for future research examining IAD treatment in acute care.

dermatology,surgery
Incontinence-Associated Dermatitis: a Practical Guide for the Consulting Dermatologist

Narges Maskan Bermudez,Brianna Christina Sa,Marita Yaghi,Abby Hargis,Scott A. Elman

DOI: https://doi.org/10.1007/s13671-023-00403-x

2023-09-14

Current Dermatology Reports

Abstract:Purpose of ReviewIncontinence-associated dermatitis (IAD) is a common irritant contact dermatitis associated with exposure to urine or feces. This review provides an overview of the etiology, diagnosis, and clinical management of IAD.Recent FindingsIncontinent patients should follow a comprehensive preventive care regimen to minimize the occurrence of IAD. This regimen includes daily and as-needed cleansing using specialized “no-rinse” cleansers to cleanse the skin, remove irritants, and provide protection. Additionally, cleansers containing miconazole may be added to provide additional defense and reduce candidal infections. To reduce frictional irritation and preserve the skin barrier, it is recommended to minimize towel drying and apply an emollient moisturizer and skin protectant. Additionally, incorporating fecal collection devices or protective hydrocolloid dressings in combination with or as alternatives to adult containment briefs has proven effective in reducing the prevalence of IAD by minimizing exposure to moisture, irritants, and friction.SummaryIAD causes significant discomfort and is a risk factor for pressure ulcers and skin infections. Elderly hospitalized patients and individuals with fecal incontinence are at a high risk for developing IAD. Diagnosing IAD can be challenging as it is often misdiagnosed as stage I and II pressure ulcers. Visual indicators of pressure ulcers include distinct lesions over bony prominences, non-blanchable erythema, and localized skin changes with or without necrosis. Prevention of IAD involves minimizing exposure to stool and/or urine and implementing a skincare regimen that includes gentle cleansing, moisturization, and application of a skin protectant.
Incontinence-Associated Dermatitis: A Comprehensive Review and Update

Beeckman, Dimitri,Selekof, Joan,Doughty, Dorothy,Fader, Mandy,Gray, Mikel,Bliss, Donna Z.,Kurz, Peter,Logan, Susan,Junkin, Joan

DOI: https://doi.org/10.1097/WON.0b013e31823fe246

2019-10-03

Abstract:In 2009, a multinational group of clinicians was charged with reviewing and evaluating the research base pertaining to incontinence-associated dermatitis (IAD) and synthesizing this knowledge into best practice recommendations based on existing evidence. This is the first of 2 articles focusing on IAD; it updates current research and identifies persistent gaps in our knowledge. Our literature review revealed a small but growing body of evidence that provides additional insight into the epidemiology, etiology, and pathophysiology of IAD when compared to the review generated by the first IAD consensus group convened 5 years earlier. We identified research supporting the use of a defined skin care regimen based on principles of gentle perineal cleansing, moisturization, and application of a skin protectant. Clinical experience also supports application of an antifungal powder, ointment, or cream in patients with evidence of cutaneous candidiasis, aggressive containment of urinary or fecal incontinence, and highly selective use of a mild topical anti-inflammatory product in selected cases. The panel concluded that research remains limited and additional studies are urgently needed to enhance our understanding of IAD and to establish evidence-based protocols for its prevention and treatment.
Meta-analysis Investigating the Efficacy of Liquid Dressing and Ostomy Powder for the Treatment of Incontinence-Associated Dermatitis

Liangbang Ma,Dan Zhou,Jie Wang,Ting Yu

DOI: https://doi.org/10.1097/ASW.0000000000000016

IF: 2.3729

2023-08-17

Advances in Skin & Wound Care

Abstract:ABSTRACT OBJECTIVE To study the effect of liquid dressing and ostomy powder on the treatment of incontinence-associated dermatitis (IAD). METHODS The authors searched PubMed, Web of Science, CNKI (China National Knowledge Internet), and Google Scholar databases for literature through July 28, 2022. After literature screening, two investigators independently extracted data from the included studies and applied the Newcastle-Ottawa Scale to assess the quality of the included studies. The χ2-based Q statistic test and the I2 statistic were used to measure the heterogeneity of the included studies. Publication bias was measured with funnel plots and the Egger test. Sensitivity analysis was conducted by eliminating each study one by one. RESULTS Four high-quality studies were included in the meta-analysis, involving a total of 307 participants. The meta-analysis results showed that compared with traditional care, treatment with liquid dressing and ostomy powder significantly improved the effective rate (pooled odds ratio, 21.42; 95% CI, 8.58 to 53.44), shortened the healing time (pooled mean difference, −10.73; 95% CI, −12.92 to −8.54), and reduced the recurrence rate (pooled mean difference, −2.03; 95% CI, −2.30 to −1.77) of IAD. Among the included studies, no publication bias was detected. Sensitivity analysis results confirmed the robustness of the pooled estimates. CONCLUSIONS Treatment with liquid dressing and ostomy powder has clinical value for patients with IAD.

Medicine
Distribution and morphology of macrophages in palatine tonsils.

Yuzo Yamamoto,S. Okato,Hiroaki Takahashi,K. Takeda,S. Magari

DOI: https://doi.org/10.3109/00016488809125010

Abstract:The distribution and morphology of macrophages were studied by immunohistochemical and electronmicroscopic methods in three diseases of the palatine tonsils: tonsillar hypertrophy, recurrent tonsillitis and tonsils with focal infection. We confirmed the presence of two types of macrophages in the tonsils, a monocyte-macrophage cell line and dendritic cells with subtypes, Langerhans' and interdigitating reticulum cells. In the lymphoepithelial symbiosis area and in the subepithelial area, the monocyte-macrophage cells and the dendritic cells had similar distributions and densities. Since these two types of cells were sometimes in contact with each other, they may function in close cooperation. In tonsils with focal infection, there were fewer dendritic cells in the lymphoepithelial symbiosis area, and the germinal centers were less well developed than in the other tonsillar diseases. These findings suggest that in tonsils with focal infection, insufficient amounts of antigen may be presented by the dendritic cells to helper T-lymphocytes.
[Clinical study of rheumatoid interstitial lung disease evaluated by high resolution CT].

Y. Okuda,K. Takasugi,A. Imai,T. Oyama,H. Oyama,S. Kawamura

1993-02-01

Abstract:High resolution computed tomographic (HRCT) scans were obtained in 215 patients with rheumatoid arthritis to assess pulmonary fibrosis (PF). We classified the HRCT appearances as five-point scale (0-4) based on the degrees of PF. The results were as follows: 1. We found 117 cases (54.4%) of PF on HRCT. 2. Patients with PF (grade 1-4) showed significantly increased leucocyte cell counts and significantly worsened pulmonary function test than patients without PF (grade 0). 3. Patients with advanced articular involvement had significantly higher prevalence of PF than others without them. 4. Patients who were previously or currently receiving gold sodium thiomalate (GST) injection or administration of methotrexate had higher prevalence of PF than others. However, patients who were receiving long term GST therapy (1 year long or sigma 1000 mg) had slightly lower prevalence of PF than others. This finding suggests that dose-dependent lung injury is not related to GST therapy. 5. Patients with advanced PF (grade 3, 4) had high prevalence of male sex, smoker, extraarticular manifestation.
[Using Teamwork to Reduce the Incidence of Incontinence-Associated Dermatitis]

An-Ting Chen,Mei-Hua Huang,Chiu-Chen Chen,I-Ting Wang,Li-Chen Chen

DOI: https://doi.org/10.6224/JN.202002_67(1).11

Abstract:Background & problems: Dermatitis associated with incontinence was the cause of 55% of the total of 386 skin lesion cases in our unit between July and December 2016 and 40.3% of the skin lesion cases in our unit during March and April 2017, indicating the importance of this issue. Our survey showed that the nurses in our unit scored an average of 78.9% on knowledge related to the prevention of incontinence-associated dermatitis and only 58.2% on knowledge related to incontinence-associated dermatitis care. The main reasons for the high incidence of incontinence-associated dermatitis included: incorrect implementation of care, no discussion with the medical team, no incontinence care standards, no continue education, lack of related equipment for preventing incontinence-associated dermatitis, unit patient characteristics, and drugs used. Purpose: To reduce the incidence of incontinence-associated dermatitis from 40.3% to 32.0%. Resolution: A care-bundle in treating incontinence-associated dermatitis was implemented by designing an assessment flow chart for evaluating incontinence-associated dermatitis, by setting standard guidelines for incontinence-associated dermatitis care, by distributing reminder cards, special toolboxes, and by changing how the little diapers were wrapped. In-service education lessons, inter-professional collaborative practice, and regular internal audit were also executed. Results: After project implementation, the knowledge score of nurses increased from 78.9% to 95.7%; the correctness of care score, as retested in November 2017, increased from 58.2% to 91.5%; and the incidence of incontinence-associated dermatitis dropped to 18.5%. These improvements achieved the goals of this project. Furthermore, the sustained effect of the project measures was confirmed, with the incidence of incontinence-associated dermatitis determined as 17.9% at three months after completion of the project. Conclusions: Formulating care procedures and cooperating with medical team personnel to provide creative care measures were shown to effectively decrease the incidence of incontinence-associated dermatitis and improve overall quality of care. The findings of this project support the revision by hospitals of regulations and procedures related to adult incontinence-associated dermatitis to provide caregivers with basis-of-care standards and uniform care procedures and standards in support of effective patient skin care regimens.
Prevention and management of urinary incontinence-associated dermatitis: A systematic review

Neslihan Atlı,Emine Kaplan Serin

DOI: https://doi.org/10.1016/j.jtv.2024.08.006

2024-09-01

Abstract:Background: To prevent incontinence-associated dermatitis (IAD) and manage the treatment, the cause of IAD must be determined correctly and distinguished from other skin problems. IAD can be prevented with professional care. Aim: This systematic review aims to systematically examine the methods used in the prevention and treatment of urinary incontinence-associated dermatitis. Materials and methods: The PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) criteria were taken as the basis for creating the systematic review protocol and writing the article. In this systematic review, the scans are combinations of words and word groups determined by the MeSH (Medical Subject Headings) terms "incontinence", "incontinence-associated dermatitis", "prevention of urinary incontinence", "treatment of urinary incontinence" and "randomized controlled". Studies conducted in the last eight years were examined in the PubMed, Cochrane Library, Web of Science, and Scopus databases between January and March 2024. Studies were selected by determining inclusion and exclusion criteria according to the PICOS method and these studies included in the review were evaluated according to the Joanna Briggs Institute (JBI) critical evaluation lists according to their types. Results: Five randomized controlled trials with a total of 644 participants were included in this systematic review. In all five studies included in the review, it was determined that pharmacological and non-pharmacological methods significantly reduced dermatitis associated with urinary incontinence. Conclusion: In the reviewed studies, it was observed that pharmacological and non-pharmacological methods had a positive effect on dermatitis in individuals with IAD. It is recommended to conduct more studies of high methodological quality, using larger sample groups, with different interventions and randomization and blinding methods, and examining the effectiveness of pharmacological and non-pharmacological methods in individuals with urinary incontinence-associated dermatitis.
Prevention and Management of Incontinence-Associated Dermatitis in the Pediatric Population: An Integrative Review

Yvonne Siew Ling Lim,Keryln Carville

DOI: https://doi.org/10.1097/WON.0000000000000490

2019-10-04

Abstract:An integrative review was conducted to synthesize evidence on prevention and management of incontinence-associated dermatitis (IAD) in the pediatric population. A 5-step integrative process was used to guide the review. Articles published from January 2000 to April 6, 2017, were identified and retrieved from CINAHL, PubMed, ProQuest (MEDLINE), and Scopus; key terms were associated with IAD, pediatric, prevention, and management. Supplemental and manual searches were carried out to identify other relevant studies. The studies' findings were extracted and summarized in a table of evidence, with their quality evaluated using the Joanna Briggs Institute's Critical Appraisal Checklist. Sixteen articles were included in the review. Articles explored prevention and management strategies including skin cleansing technique, diaper selection, and the application of topical skin care products. Inconsistent and limited evidence was found regarding the benefits of using disposable wipes in preference to water-moistened washcloths in the cleansing process and on the use of superabsorbent polymer diapers with breathable outer lining in IAD prevention. Findings were inconclusive with regard to the best topical skin care product for IAD care. However, the application of skin protectants was encouraged by the authors, as well as promoted in various clinical guidelines. The development of a structured skin care regimen supplemented by a comprehensive patient education program was advised to enhance the prevention and management of IAD.
Managing incontinence-associated dermatitis in the community: an overview

Francesca Ramadan

DOI: https://doi.org/10.12968/bjcn.2024.29.6.294

2024-06-02

Abstract:Incontinence-associated dermatitis (IAD) is often treated a hygienic challenge, rather than a serious condition with potentially life-threatening consequences. More appropriate education on the management strategies specific to IAD is required, in order for personalised and effective care that reflects the critical nature of this condition to be provided. Francesca Ramadan provides an overview of the key elements of best practice in IAD management and treatment.
Decreasing the Rate of Incontinence-Associated Dermatitis in Intensive Care Units: A Quality Improvement Project

Yi Chen,Lan Gu,Yan Lu,Wei Ding,SiMin Cheng

DOI: https://doi.org/10.1016/j.jtv.2024.09.010

IF: 3.374

2024-10-01

Journal of Tissue Viability

Abstract:Highlights • Reduced IAD in ICU : Significant decrease in dermatitis incidence. • Nursing Training Enhanced : Specialized incontinence care workshops held. • PDSA Model Success : Improved nursing quality indicators over 36 months. • New Skin Care Protocol : Early care with perineum ventilation implemented. • Continuous Quality Control : Annual reviews to boost incontinence care. Purpose Patients in the intensive care unit (ICU) are at a high risk of developing incontinence-associated dermatitis (IAD), the incidence and severity of which are positively related to pressure injuries, thus affecting nursing quality indicators. This quality improvement project aimed to decrease the severity and incidence of IAD, with a focus on enhancing awareness among nursing staff. Design This 36-month project was implemented via the Plan-Do-Study-Act (PDSA) model. Subjects and setting: Included staff members worked in the ICUs (central and emergency ICUs) at a Grade A tertiary hospital in Suzhou (South of Jiangsu), China. Methods The quality improvement project included three main procedures: (1) formulating and implementing a modified prevention and treatment nursing protocol for early structured skin care with perineum ventilation, formulating a guidance sheet for incontinence nursing care; (2) organizing training and assessments of theories and skills, including three special sections on incontinence care training (theoretical knowledge, project process, video watching), skills training for nursing staff, and an incontinence nursing workshop to engage and evaluate all staff; (3) annual analysis and discussion of nursing quality control. Results Following project completion, there was a decrease in the overall incidence of IAD. Moreover, ICU nurses may attach more importance/awareness to IAD. Conclusions This project successfully reduced the incidence of IAD among ICU patients.

dermatology,nursing
The Prevalence of Incontinence-Associated Dermatitis in Hospitalized Patients in China: A Systematic Review and Meta-Analysis

Min Wei,Dongliang Yang,Ling Wu,Wenyue Chen,Yan Chen,Qiaomei Fu

DOI: https://doi.org/10.1097/01.ASW.0000695764.47424.aa

Abstract:Objective: To determine the prevalence and characteristics of incontinence-associated dermatitis (IAD) among hospitalized Chinese patients. Data sources: Authors searched Chinese (China National Knowledge Infrastructure, Wanfang Data, VIP Data, Chinese Biomedicine) and English (PubMed, Web of Science) electronic databases for articles published from 1987 through February 2019. Study selection: The preliminary search identified 558 studies. After removal of duplicates (n = 202), application of exclusion criteria, and screening titles and abstracts (n = 346), 10 studies met the inclusion criteria. Data extraction: A standardized form was constructed to extract data from eligible studies, and this information was extracted by two independent authors. Data synthesis: A pooled analysis of the 10 studies (total sample size, 40,039) showed the prevalence of IAD in hospitalized Chinese patients was 1.44% (95% confidence interval, 1.10%-1.79%). Subgroup analysis indicated no significant association between sex and IAD. Patients older than 90 years had the highest incidence of IAD (8.64%). The most common type was mild IAD (1.00%). Fecal incontinence (48.02%) led to more cases of IAD than urinary incontinence (11.35%) or both (25.78%). The most common types of IAD were perineal (0.92%) and perianal (0.90%). Conclusions: Incontinence-associated dermatitis is a global health problem that requires more attention. Understanding the prevalence and characteristics of IAD is helpful in the formulation of IAD prevention and treatment programs in China.
Incontinence-Associated Dermatitis: Consensus Statements, Evidence-Based Guidelines for Prevention and Treatment, and Current Challenges

Dorothy Doughty,Joan Junkin,Peter Kurz,Joan Selekof,Mikel Gray,Mandy Fader,Donna Z. Bliss,Dimitri Beeckman,Susan Logan,Doughty, Dorothy,Selekof, Joan,Beeckman, Dimitri,Fader, Mandy,Gray, Mikel,Bliss, Donna Z.,Kurz, Peter,Junkin, Joan,Logan, Susan

DOI: https://doi.org/10.1097/WON.0b013e3182549118

2019-10-03

Abstract:In 2010, an international consensus conference was held to review current evidence regarding the pathology, prevention, and management of incontinence-associated dermatitis (IAD). The results of this literature review were published in a previous issue of this Journal. This article summarizes key consensus statements agreed upon by the panelists, evidence-based guidelines for prevention and management of IAD, and a discussion of the major challenges currently faced by clinicians caring for these patients. The panelists concur that IAD is clinically and pathologically distinct from pressure ulcers and intertriginous dermatitis, and that a consistently applied, structured, or defined skin care program is effective for prevention and management of IAD. They also agreed that differential assessment of IAD versus pressure ulceration versus intertriginous dermatitis remains a major challenge. Panel members also concur that evidence is lacking concerning which products and protocols provide the best outcomes for IAD prevention and treatment in individual patients. Issues related to differential assessment, product labeling and utilization, staff education, and cost of care are the primary focus of this article.
Risk Factors for Incontinence-Associated Dermatitis in Critically Ill Patients with Incontinence: A Systematic Review and Meta-analysis

Guandong Wang,Xueying Wang,Haibo Wang,Liang Wang,Wenjuan Li

DOI: https://doi.org/10.1097/WON.0000000000001090

Abstract:Purpose: This systematic review analyzed evidence related to risk factors for Incontinence Associated Dermatitis (IAD) in critically ill incontinent patients. Method: Systematic review and meta-analysis. Search strategy: Eight databases, including PubMed, Embase, CINAHL, Cochrane Library, and Web of Science, were searched for studies published in the English language. The China National Knowledge Infrastructure, WanFang Data, and Chinese Scientific Journal Database were also searched for studies evaluating risk of IAD in critically ill incontinent patients published in the Chinese language. Findings: Twenty-four studies with moderate-to-high methodological quality were included. Significant risk factors for developing IAD were being older [odds ratio (OR) = 1.06, 95% confidence interval (CI): 1.02-1.10, P = .007], fever (OR = 2.57, 95% CI: 1.87-3.57, P < .00001), diagnosed with consciousness disorder (OR = 5.70, 95% CI: 2.28-14.22, P = .0002), having higher Acute Physiology and Chronic Health Evaluation (APACHE) II score (OR = 1.71, 95% CI: 1.25-2.35, P = .0009), lower Braden score (OR = 0.73, 95% CI: 0.56-0.96, P = .02), lower oxygen saturation (OR = 2.76, 95% CI: 1.52-5.00, P = .0008), double incontinence (OR = 4.10, 95% CI: 2.34-7.17, P < .00001), liquid stool (OR = 6.55, 95% CI: 4.12-10.41, P < .00001), frequent incontinence (OR = 1.21, 95% CI: 1.03-1.43, P = .02), and higher perineal assessment tool (PAT) score (OR = 3.18, 95% CI: 1.76-5.76, P = .0001). Implications: Findings of this systematic review and meta-analysis suggest that healthcare providers should consider risk factors such as older age, fever, consciousness disorder, higher APACHE II score, lower Braden score and double incontinence matter when developing strategies for the prevention and management of IAD in critically ill incontinent patients.
The role of Candida spp. contamination and efficacy of camphorated oil in skin care of incontinent associated dermatitis patients

Ihor Kohut,Svitlana Galnykina,Mariia Kushynska,Inna Krynytska,Mariya Marushchak,Aleksandr Kamyshnyi

2020-04-22

Abstract:Candida albicans is the most prevalent human fungal commensal organism and is reported to be the most frequent aetiological factor responsible for infection associated with incontinence-associated dermatitis (IAD). Aim: The aim of the study was to investigate the Candida spp. colonisation and efficacy of camphorated oil in the skin care of the patients with incontinence-associated dermatitis. Materials and methods: In patients of the study group (n=104), a local application of camphorated oil was used to clean and protect their skin from urine and/or faeces. In 30 patients of the control group routine wet wipes 3 in 1 or a combination of cleansing foam with protective cream were used. Pre-treatment (day 1) and post-treatment (day 30±1) study evaluations included detailed description of eruption, assessment by evaluation tools, and mycological culture for Candida spp. from sites with fungal-appearing rash. Results: Fungal-appearing rash was found in almost a half (51.0%) of patients at pre-treatment examination and in less than one-third (31.7%) of the patients after the course of application of camphorated oil. Candida spp. was cultivated in 39 (37.5%) patients. Fungal-appearing rash was approved by mycological culture in 56.6%. In patients with urine incontinence, Candida spp. negative cases (43.3%) were significantly prevalent over Candida spp. positive (22.1%). At post-treatment, this prevalence become more noticeable, accordingly obtaining 62.5% of negative and 2.9% of positive results. In patients with double incontinence, Candida spp. negative cases (19.2%) were almost equal to the number of Candida spp. positive (15.4%). After a course of study treatment, Candida spp. negative cases (26.0%) significantly overpassed Candida spp. positive level (8.7%). At an early and moderate grade of IAD Candida spp. negative cases were prevalent, but at severe grade did not differ from the number of positive mycology cultures. Conclusions: The topical use of camphorated oil in skin care of the incontinence-associated dermatitis significantly decreases the severity of disease, reduces fungal appearing rash and Candida spp. colonisation. Camphorated oil was superior to routine products in the controlling of yeast colonisation of the skin in incontinence-associated dermatitis, especially in cases with double incontinence.
Management of incontinence‐associated dermatitis: A systematic review of monetary data

Charlotte Raepsaet,Anika Fourie,Ann Van Hecke,Sofie Verhaeghe,Dimitri Beeckman

DOI: https://doi.org/10.1111/iwj.13496

2020-11-25

International Wound Journal

Abstract:The objective was to systematically review monetary data related to management of incontinence‐associated dermatitis (IAD) in an adult population. Six electronic databases were searched: MEDLINE, CINAHL, Web of Science, EMBASE, The Cochrane Library and EconLit. The search string combined index terms and text words related to IAD and monetary data. The quality of the articles was assessed using the consensus on Health Economic Criteria. Results were synthesised narratively because of methodological heterogeneity. Nine studies were included. Only direct medical costs were reported. The product cost per application for prevention ranged between $0.05 and $0.52, and for treatment between $0.20 and $0.35. The product cost per patient/day for prevention ranged between $0.23 and $20.17. The product cost of IAD prevention and treatment per patient/day ranged between $0.57 and $1.08. The cost to treat IAD did not consider the treatment of secondary infection. The calculation of labour cost and total cost differed considerably between studies. Summarising monetary data is a challenge because of heterogeneity in currencies, settings, samples, time horizons, health‐ and cost outcome valuation, IAD definition and measurements, and included costs. Procedures for health economic evaluations are to be clarified to guarantee valid interpretation and comparison with other studies.

dermatology,surgery
Decreasing Incontinence-Associated Dermatitis in the Surgical Intensive Care Unit: A Quality Improvement Project

Brandon P Gates,Joy Vess,Mary Arnold Long,Emily Johnson

DOI: https://doi.org/10.1097/WON.0000000000000540

Abstract:Purpose: The purpose of this quality improvement (QI) project was to determine if use of an algorithm focusing on skin care in patients with fecal and urinary incontinence reduces the rate of hospital-acquired incontinence-associated dermatitis (IAD) over a period of 4 months. Participants and setting: The QI setting was an 18-bed surgical intensive care unit (SICU) in an acute care urban hospital located in the southeastern United States. Two hundred eleven patients participated in this pre/postintervention QI project. Approach: The algorithm for skin care used evidence-based bundled interventions for patients with fecal and urinary incontinence. The project comprised education of the SICU nursing staff in January 2018 and implementation of the algorithm from February 5, 2018, to June 5, 2018. Weekly chart reviews were conducted to determine algorithm compliance, documentation of fecal and urinary incontinence, and accuracy of IAD documentation. Descriptive statistics were used to determine the rate of hospital-acquired IAD, algorithm compliance, and average length of time from admission to the onset of hospital-acquired IAD. Outcomes: Seventy-nine individuals with incontinence were included in the 3-month preintervention period and 132 individuals with incontinence in the 3-month postintervention period. We observed a 24% reduction in the rate of hospital-acquired IAD following implementation of the algorithm (29% vs 5%). The average length of time from admission to the onset of hospital-acquired IAD increased from 15 days in February 2018 to 25 days in May 2018. Implications for practice: Our experience with this QI project suggest that IAD can be identified and managed at the bedside by first clinical nursing staff without expertise in skin assessment and wound care.

[Release of polymorphic forms of progesterone from dimethylpolysiloxane matrices].

The pH‐Dependent Local Anesthetic Activity of Diethylaminoethanol, a Procaine Metabolite

Optimal Management of Incontinence-Associated Dermatitis in the Elderly

Effectiveness of skin cleanser and protectant regimen on incontinence‐associated dermatitis outcomes in acute care patients: A cluster randomised trial

Incontinence-Associated Dermatitis: a Practical Guide for the Consulting Dermatologist

Incontinence-Associated Dermatitis: A Comprehensive Review and Update

Meta-analysis Investigating the Efficacy of Liquid Dressing and Ostomy Powder for the Treatment of Incontinence-Associated Dermatitis

Distribution and morphology of macrophages in palatine tonsils.

[Clinical study of rheumatoid interstitial lung disease evaluated by high resolution CT].

[Using Teamwork to Reduce the Incidence of Incontinence-Associated Dermatitis]

Prevention and management of urinary incontinence-associated dermatitis: A systematic review

Prevention and Management of Incontinence-Associated Dermatitis in the Pediatric Population: An Integrative Review

Managing incontinence-associated dermatitis in the community: an overview

Decreasing the Rate of Incontinence-Associated Dermatitis in Intensive Care Units: A Quality Improvement Project

The Prevalence of Incontinence-Associated Dermatitis in Hospitalized Patients in China: A Systematic Review and Meta-Analysis

Incontinence-Associated Dermatitis: Consensus Statements, Evidence-Based Guidelines for Prevention and Treatment, and Current Challenges

Risk Factors for Incontinence-Associated Dermatitis in Critically Ill Patients with Incontinence: A Systematic Review and Meta-analysis

The role of Candida spp. contamination and efficacy of camphorated oil in skin care of incontinent associated dermatitis patients

Management of incontinence‐associated dermatitis: A systematic review of monetary data

Decreasing Incontinence-Associated Dermatitis in the Surgical Intensive Care Unit: A Quality Improvement Project